These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18855703)

  • 1. Current dendrimer applications in cancer diagnosis and therapy.
    Majoros IJ; Williams CR; Baker JR
    Curr Top Med Chem; 2008; 8(14):1165-79. PubMed ID: 18855703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimer-based nanoparticles for cancer therapy.
    Baker JR
    Hematology Am Soc Hematol Educ Program; 2009; ():708-19. PubMed ID: 20008257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.
    Cheng Y; Zhao L; Li Y; Xu T
    Chem Soc Rev; 2011 May; 40(5):2673-703. PubMed ID: 21286593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrimer and cancer: a patent review (2006-present).
    Cai X; Hu J; Xiao J; Cheng Y
    Expert Opin Ther Pat; 2013 Apr; 23(4):515-29. PubMed ID: 23339480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and diagnostic applications of dendrimers for cancer treatment.
    Wolinsky JB; Grinstaff MW
    Adv Drug Deliv Rev; 2008 Jun; 60(9):1037-55. PubMed ID: 18448187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.
    Sharma AK; Gothwal A; Kesharwani P; Alsaab H; Iyer AK; Gupta U
    Drug Discov Today; 2017 Feb; 22(2):314-326. PubMed ID: 27671487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Oncological Submissions of Dendrimer.
    Soni N; Tekade M; Kesharwani P; Bhattacharya P; Maheshwari R; Dua K; Hansbro PM; Tekade RK
    Curr Pharm Des; 2017 Aug; 23(21):3084-3098. PubMed ID: 28356042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrimers in oncology: an expanding horizon.
    Tekade RK; Kumar PV; Jain NK
    Chem Rev; 2009 Jan; 109(1):49-87. PubMed ID: 19099452
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
    Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
    Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic applications of smart nanocomposite dendrimers.
    Kumar V; Sahoo RK; Basak T; Yasmin T; Gupta U; Goyal AK
    Front Biosci (Landmark Ed); 2021 Jan; 26(3):518-536. PubMed ID: 33049681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled Dendrimers for Nuclear Medicine Applications.
    Zhao L; Zhu M; Li Y; Xing Y; Zhao J
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28841180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy.
    Surekha B; Kommana NS; Dubey SK; Kumar AVP; Shukla R; Kesharwani P
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111837. PubMed ID: 33992888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimers in cancer therapeutics and diagnosis.
    Guo R; Shi X
    Curr Drug Metab; 2012 Oct; 13(8):1097-109. PubMed ID: 22380011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
    Tomalia DA; Reyna LA; Svenson S
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in dendrimer-based nanomedicine development.
    Kim Y; Park EJ; Na DH
    Arch Pharm Res; 2018 Jun; 41(6):571-582. PubMed ID: 29450862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modified dendrimers: synthesis and characterization for cancer targeted drug delivery.
    Sharma A; Gautam SP; Gupta AK
    Bioorg Med Chem; 2011 Jun; 19(11):3341-6. PubMed ID: 21570304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendrimer nanoparticles for colorectal cancer applications.
    Carvalho MR; Reis RL; Oliveira JM
    J Mater Chem B; 2020 Feb; 8(6):1128-1138. PubMed ID: 31971528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
    Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
    Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation.
    Kaminskas LM; McLeod VM; Porter CJ; Boyd BJ
    Mol Pharm; 2012 Mar; 9(3):355-73. PubMed ID: 22250750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.